
TAXA Biotechnologies YCアプリケーション
TAXA BiotechnologiesはSummer 2014バッチでHealthcare企業としてY Combinatorを卒業しました。以下:会社の事業内容、創業者、そして実際のYCフォームで質問ごとに再構築されたYCへの応募内容。
- YCバッチ
- Summer 2014
- 業界
- HealthcareConsumer Health and Wellness
- チーム規模
- 2
- ステータス
- Inactive
- ローンチ済み
- 2014
創業者
Antony EvansFounder/CEO
TAXA Biotechnologiesの事業内容
The TAXA platform has been specifically designed to enable anyone to perform metabolic engineering of plants without stepping into a lab. We provide access to protein engineering, DNA assembly, transient experiments and stable transformation as a service. The best thing is that anything "Powered by TAXA" is designed to be free from expensive regulatory approval, meaning the products are available for sale or distribution to consumers in the United States immediately after they are developed. For a detailed list of the experiments which can be run on our platform please see the Services page. Our vision is a world where bio-engineering is as easy and commonplace as mobile application development is today. Game-changing technologies, like genetic engineering, should not be the exclusive preserve of large corporations and a wealthy elite. Democratizing the tools of creation enables anyone, anywhere, to genetically engineer plants and will unleash a wave of creativity to power an environment where ultimately what we create is limited only by our imagination. The TAXA platform is our next step in the realization of that dream We are also the team behind the first synthetic biology crowdfunding project, raising $484k on Kickstarter to make real glowing plants:
TAXA BiotechnologiesのYCアプリケーション、再構築済み
Y Combinator 申請
TAXA Biotechnologies 様、Summer 2014 バッチ。公開データから回答された、実際のフォームの質問。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
TAXA Biotechnologies
Cheaper, faster, better genetic engineering of plants
We built the TAXA platform to let anyone perform metabolic engineering on plants without needing a lab. It offers protein engineering, DNA assembly, transient experiments, and stable transformation as services. Our platform is unique because anything created with it is designed to be free from costly regulatory approval, so products can reach customers in the US immediately after development.
We live in San Francisco, CA and plan for the company to remain based here after YC.
San Francisco is where we are based because it offers access to biotech talent and a strong startup ecosystem connected to healthcare and genetic engineering.
よくある質問
TAXA Biotechnologiesの実際のYCアプリケーションですか?
いいえ。Y Combinatorは提出されたアプリケーションを非公開にしています。これは再構築されたものです。実際のYCフォームの質問に、TAXA Biotechnologiesの公開データ(ローンチノート、創業者経歴、製品説明)から回答しています。TAXA Biotechnologiesのような会社がYCにどのようにアピールするかを示しており、彼らが提出したテキストではありません。
TAXA BiotechnologiesはどのYCバッチに参加しましたか?
TAXA BiotechnologiesはY CombinatorのSummer 2014バッチに参加しました。
TAXA Biotechnologiesは誰によって設立されましたか?
TAXA BiotechnologiesはAntony Evansによって設立されました。
TAXA Biotechnologiesは何をしていますか?
We enable cheaper, faster, and better genetic engineering of plants.…
完全な再構築されたアプリケーションはどのように読めばよいですか?
無料のRound Fundedアカウントを作成してください。 TAXA Biotechnologiesの26つの回答からなる完全なアプリケーションと、他のすべてのYCバッチはYC Insightsにあります。